| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 8, 2021 | ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience | NEW YORK and SAN DIEGO, Calif., September 8, 2021/PR NEWSWIRE/ – ATP, a leader in life sciences venture capital, today announced the launch of Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer, and treat a... |
| Sep 8, 2021 | ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience | |
| Sep 8, 2021 | ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience | NEW YORK and SAN DIEGO, Calif., September 8, 2021/PR NEWSWIRE/ – ATP, a leader in life sciences venture capital, today announced the launch of Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer, and treat a... |
| Sep 8, 2021 | ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience | NEW YORK and SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- ATP, a leader in life sciences venture capital, today announced the launch of Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer, and treat autoimmune a... |
| Oct 27, 2020 | Trailblazer Kesha Cash Raises $55 Million For Impact America Fund | 12 Shares Email Facebook Twitter LinkedIn
Impact America Fund founder and General Partner Kesha Cash has closed on a second institutional fund at $55 million. Impact America Fund is one of the largest fund raises led by a Black female gener... |
| Oct 27, 2020 | Trailblazer Kesha Cash Raises $55 Million For Impact America Fund | 11 Shares Email Facebook Twitter LinkedIn
Impact America Fund founder and General Partner Kesha Cash has closed on a second institutional fund at $55 million. Impact America Fund is one of the largest fund raises led by a Black female gener... |